Related references
Note: Only part of the references are listed.New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
CME Information: Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification, and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort
Omur Gokmen Sevindik et al.
Clinical Lymphoma Myeloma & Leukemia (2015)
Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2015)
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
T. Barbui et al.
BLOOD CANCER JOURNAL (2015)
Myeloproliferative Neoplasms A Contemporary Review
Ayalew Tefferi et al.
JAMA ONCOLOGY (2015)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients
Rongfeng Fu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
Tiziano Barbui et al.
BLOOD (2012)
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
Alessandra Carobbio et al.
BLOOD (2011)
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
Alberto Alvarez-Larran et al.
BLOOD (2010)
Share Paper
